DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Irenic - 1 Oleg Movchan - 1 Enfusion - 1 Adam Katz - 1 Andy Dodge - 1 Katz - 1 Dodge - 1 Elliott - 1
Top related locs:
Vista
Top related orgs:
YORK - 1 Enfusion Inc - 1 Francisco Partners - 1 Vista Equity Partners - 1 Irenic Capital Management - 1 Francisco - 1 Elliott Management - 1 Indaba - 1

Search resuls for: "Andy Dodge"


5 mentions found


☆ Exclusive: Software company Enfusion draws takeover interest from private equity, Irenic Capital
  + stars: | 2023-06-26 | by ( Svea Herbst-Bayliss | ) www.reuters.com   time to read: +2 min
NEW YORK, June 26 (Reuters) - Software company Enfusion Inc (ENFN.N) is attracting takeover interest from private equity firms and strategic buyers, several people familiar with the matter said. Enfusion's management has been approached in recent months by Francisco Partners, Vista Equity Partners and investment firm Irenic Capital Management, said the sources who asked not to be identified because the talks are private. The company has experienced turbulence in the executive ranks, with its chief executive officer and chief financial officer resigning just months apart from one another last year. The name of the private equity partner could not be learned. Irenic, which was co-founded by Elliott Management veteran Adam Katz and former Indaba Capital partner Andy Dodge, recently worked with private equity giant Apollo Global Management to buy industrial parts manufacturer Arconic.
Persons: Irenic, Oleg Movchan, Enfusion, Adam Katz, Andy Dodge, Katz, Dodge, Elliott, Deutsche Boerse, Svea Herbst, Bayliss, Nick Zieminski Organizations: YORK, Enfusion Inc, Francisco Partners, Vista Equity Partners, Irenic Capital Management, Francisco, Elliott Management, Indaba, Apollo Global Management, Arconic, Harvard, Nasdaq, Deutsche, Svea, Thomson Locations: Vista
☆ Exclusive: Irenic Capital urges Theravance to conduct review, add shareholder to board
  + stars: | 2023-02-27 | by ( Svea Herbst-Bayliss | ) www.reuters.com   time to read: +3 min
NEW YORK, Feb 27 (Reuters) - Activist investor Irenic Capital Management is urging Theravance Biopharma Inc (TBPH.O) to initiate a review of strategic alternatives, including a full sale, and to add a shareholder to its board, according to a letter seen by Reuters. Irenic owns a 4.2% stake in the biotechnology company and has criticized its lagging valuation and stock-based compensation to its chief executive and board chair, Rick Winningham. Irenic also called on Theravance to use excess cash to immediately issue a $300 million special dividend to shareholders. They suggested Dodge as a director candidate but wrote in the letter that the company rejected him as a candidate. Irenic is the latest hedge fund to propose changes at poorly performing biotech companies.
☆ Everyone wants to be an activist investor these days. Insiders like Carl Icahn lay out why it's not as easy as it looks.
  + stars: | 2022-12-15 | by ( Daniel Geiger | Rebecca Ungarino | Casey Sullivan | ) www.businessinsider.com   time to read: +12 min
Carl Icahn had a textbook strategy for the Nevada-based energy utility Southwest Gas Holdings. In August, Southwest Gas' board decided against a divestiture, and the sale of subsidiaries that Icahn had urged remains uncertain. "Shareholders don't want to hear it, but you really have great difficulty selling a company at a good price today," the widely followed activist investor Icahn told Insider. via CNBCBut, like Icahn in the case of Southwest Gas, participants in this new onslaught may find themselves confounded by an increasingly complex and fraught business environment. According to Lazard, 37% of activist campaigns this year were launched by first-timers, the highest proportion since the company started tracking these figures in 2015.
☆ Sinking stocks have helped activist campaigns surge. But giants like Carl Icahn say the business is riskier than ever.
  + stars: | 2022-12-14 | by ( Daniel Geiger | Rebecca Ungarino | Casey Sullivan | ) www.businessinsider.com   time to read: +12 min
Carl Icahn had a textbook strategy for the Nevada-based energy utility Southwest Gas Holdings. In August, Southwest Gas' board decided against a divestiture, and the sale of subsidiaries that Icahn had urged remains uncertain. That means that the sale of companies like Southwest Gas is off the table for the time being — or will get done at prices far lower than before. via CNBCBut, like Icahn in the case of Southwest Gas, participants in this new onslaught may find themselves confounded by an increasingly complex and fraught business environment. According to Lazard, 37% of activist campaigns this year were launched by first-timers, the highest proportion since the company started tracking these figures in 2015.
☆ EXCLUSIVE Hedge fund Irenic asks Capricorn Energy to ditch NewMed deal
  + stars: | 2022-10-19 | by ( Svea Herbst-Bayliss | ) www.reuters.com   time to read: +3 min
The company's stock price closed up 0.25% at 244.60 penceThe NewMed transaction would result in Capricorn being paid a $620 million special dividend. It would also leave them with a 10.3% stake in the combined company, with NewMed shareholders owning 89.7%. A liquidation could value Capricorn's assets at 350 pence per share, versus the 254 pence-per-share valuation in the NewMed deal, according to Irenic. "The company has yet to present shareholders with any proposal that represents superior value relative to the straightforward liquidation value we have assessed," Irenic wrote in the letter. Prior to agreeing on a sale to NewMed, Capricorn scrapped plans to merge with Tullow Oil Plc (TLW.L) in a deal that would have valued Capricorn shares at 210 pence and would have given Capricorn investors 47% of the new entity.
0 next >>
Total: 5